KEYNOTE-001 reported that PD-L1 expression in pretreatment tumor biopsies of melanoma correlated with response rate, PFS, and OS, though it was also observed that patients with PD-L1-negative tumors also exhibited treatment response (106). This evidence concerns the gene CD274 and melanoma.